In its injectables business, Hikma said a good mix of products will generate operating profit margins of 39%, up from the 38% previously anticipated. Respiratory drugs have in the past proved ...

“Hikma was part of an industry that flooded the country with dangerous opioids, profiting off the products that have caused our current national public health crisis,” commented New York ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma ... We are also benefitting from sustained good demand for our own products in Europe, including in our new markets. Our MENA Injectables ...

Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC ...

Analyst Christian Glennie from Stifel Nicolaus reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) and keeping the ...

Use this chart to quickly understand the differences between the various GI Bill programs. The Department of Veterans Affairs will begin to phase out the Montgomery GI Bill in 2030. Whether you ...

The acquisition will add eight approved and marketed injectable products to Hikma's US portfolio, and 11 pipeline products.

Hikma Pharmaceuticals (GB:HIK) has released an update. Hikma Pharmaceuticals has decided to reappoint PricewaterhouseCoopers LLP as its external auditor starting in 2026, following a competitive ...

In a remarkable recognition of Assam’s cultural diversity and traditional knowledge, the Geographical Indications (GI) ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.99% to £19.98 Friday, on what proved to be an all-around dismal trading session for the stock market, with the FTSE 100 Index UKX falling 0. ...

Shares of Hikma Pharmaceuticals PLC HIK inched down 0.60% to £18.26 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the FTSE 100 Index UKX falling 1.22% to ...